In this issue:
– Pregnancy after breast cancer in BRCA carriers
– Postoperative radiotherapy omission in early breast cancer
– Neoadjuvant sacituzumab govitecan for localised triple negative breast cancer
– Third-line treatment for metastatic triple-negative breast cancer
– Sacituzumab govitecan in HR-positive and HER2-negative metastatic breast cancer
– Adherence to cancer prevention recommendations and risk of lifestyle-related cancers
– Analysis of US breast cancer mortality 1975 to 2019
– Ten-year follow-up of women at high risk of familial breast and ovarian cancer
– Patient decision-making for mastectomy alone or breast reconstruction
– Patient determinants of breast cancer treatment
Expert contributor
MB BCh (UK) FRCP(Lon) MRCPS(Glas) FRACP David Okonji specialises in treating breast and urogenital cancers, as well as melanoma. He has a particular focus on cancer care in the elderly. David currently practises at Wellington Regional Hospital and also undertakes private practice at Bowen Hospital, Wellington. _ David is a Clinical Senior Lecturer at the […]
Expert contributor
Dr Popadich is a Breast, Endocrine and General Surgeon based in Wellington, working from Wakefield and Boulcott hospitals. Her main focus is surgical treatment of breast cancers and management of thyroid and parathyroid conditions. She is a member of the American Society of Breast Surgeons, the International Association of Endocrine Surgeons, the Australian and New […]
Stay up to date with our latest clinical information.
Dive into our publications and videos content from over 50 areas of medicine including Cardiology, Diabetes, Oncology, Haematology and Psychiatry.
Website terms of use
By using our website, you agree to follow these terms and conditions.
Privacy policy
We take your privacy seriously. To understand how we collect, use, and protect your information, please read our Privacy Policy, which is part of these terms.
Copyright and use of website content
The content of our website is protected by copyright, trademarks, and other legal rights. You can: view, download, or print a single copy of content for your personal or professional use.
You cannot: copy, modify, or distribute website content, or use our website content for commercial purposes or in other works without permission.
Links to third-party websites
The Research Review website may link to third-party websites for your convenience. However:
We do not endorse or approve their products, services, or actions.
We are not responsible for their content or how they operate.
There is no formal partnership between us and third parties unless we clearly state otherwise.
Disclaimer and limitation of liability
We do our best to keep the information on our website accurate, but we do not guarantee that it is always correct or up to date.
To the fullest extent allowed by law, we are not responsible for:
Any loss, damage, or costs you may suffer from using (or being unable to use) our website.
Any decisions you make based on the information provided.
Any business losses, such as lost profits, lost data, or business interruptions.
Governing law
These terms are governed by New Zealand law. If there is a dispute, it must be resolved in a New Zealand court.